Expiratory dysfunction in young dogs with golden retriever muscular dystrophy

• DOI: 10.1016/j.nmd.2020.09.027
• Publication Date: 2020-09-20T14:30:23Z
• Authors: Eleanor C. Hawkins; Amanda K. Bettis; Joe N. Kornegay
• Keywords: Diaphragm; Peak Expiratory Flow Rate; Muscular Dystrophy, Animal; Respiratory Function Tests; Muscular Dystrophy, Duchenne; Disease Models, Animal; 03 medical and health sciences; Dogs; 0302 clinical medicine; Exhalation; Animals; Dog Diseases

Respiratory disease is a leading cause of morbidity in people with Duchenne muscular dystrophy and also occurs in the golden retriever muscular dystrophy (GRMD) model. We have previously shown that adult GRMD dogs have elevated expiratory flow as measured non-invasively during tidal breathing. This abnormality likely results from increased chest and diaphragmatic recoil associated with fibrosis and remodeling. Treatments must reverse pathologic effects on the diaphragm and other respiratory muscles to maximally reduce disease morbidity and mortality. Here, we extended our work in adults to younger GRMD dogs to define parameters that would be helpful in preclinical trials. Tidal breathing spirometry and respiratory inductance plethysmography were performed in GRMD dogs at approximately 3 and 6 months of age, corresponding to approximately 5-10 years in DMD, when clinical trials are often conducted. Expiratory flows were markedly elevated in GRMD versus normal dogs at 6 months. Values increased in GRMD dogs between 3 and 6 months, providing a 3-month window to assess treatment efficacy. These changes in breathing mechanics have not been previously identified at such an early age. Expiratory flow measured during tidal breathing of unsedated young GRMD dogs could be a valuable marker of respiratory mechanics during preclinical trials.